Загрузка...
Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
Evidence about the treatment of hospitalized type 2 diabetes patients with incretin‐based therapy has emerged in the past 15 years. Based on this evidence, dipeptidyl peptidase‐4 inhibitors should be considered for hospitalized patients with type 2 diabetes and an algorithm for this is proposed. In...
Сохранить в:
| Опубликовано в: : | J Diabetes Investig |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078129/ https://ncbi.nlm.nih.gov/pubmed/31529777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13130 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|